| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5955865 | Chest | 2013 | 8 Pages |
Abstract
Add-on omalizumab is associated with a significantly decreased risk of hospitalization or ED visits in patients with uncontrolled severe asthma in real-life practice.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Lamiae PharmD, PhD, Mahmoud MD, PhD, Michel MD, PhD, Marc MD, PhD, Jean MD, Jacques MD, PhD, Mathieu MD, PhD, Lucien MD, PhD,